Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 2/2018

05.01.2018 | Clinical Investigation

Long-term clinical course of 2 Japanese patients with PRPF31-related retinitis pigmentosa

verfasst von: Kentaro Kurata, Katsuhiro Hosono, Yoshihiro Hotta

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the long-term clinical course of 2 patients with PRPF31-related retinitis pigmentosa (RP).

Patients and methods

We clinically examined 2 unrelated patients with RP and collected peripheral blood samples from them. Ophthalmic examinations, including best-corrected visual acuity measurements, Goldmann perimetry, full-field electroretinography, fundus autofluorescence imaging, and optical coherence tomography, were also performed. The visual acuity and visual field were continuously monitored. To identify the causative mutations, 74 genes known to cause RP or Leber congenital amaurosis were examined via targeted next-generation sequencing.

Results

The clinical courses of both patients were similar. The onset of nyctalopia occurred in the first decade. Fundus examination showed typical RP. Although the patients’ visual acuity was relatively preserved even into the fourth decade, the visual field area exhibited rapid deterioration in the mid-teens, with severe concentric constriction in the third decade. Mutation analysis revealed PRPF31 mutations as the cause for autosomal dominant RP in both patients.

Conclusions

To the best of our knowledge, few reports of long-term observations pertaining to patients with PRPF31-related RP have been published. The findings reported herein, especially those relating to the progressive degeneration of the visual field, may ultimately play a role in the provision of high-quality counseling for patients with this condition.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chizzolini M, Galan A, Milan E, Sebastiani A, Costagliola C, Parmeggiani F. Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking. Curr Genom. 2011;12:260–6.CrossRef Chizzolini M, Galan A, Milan E, Sebastiani A, Costagliola C, Parmeggiani F. Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking. Curr Genom. 2011;12:260–6.CrossRef
2.
Zurück zum Zitat Hotta Y, Shiono T, Hayakawa M, Hashimoto T, Kanai A, Nakajima A, et al. Molecular biological study of the rhodopsin gene in Japanese patients with autosomal dominant retinitis pigmentosa (in Japanese). Nippon Ganka Gakkai Zasshi. 1992;96:237–42.PubMed Hotta Y, Shiono T, Hayakawa M, Hashimoto T, Kanai A, Nakajima A, et al. Molecular biological study of the rhodopsin gene in Japanese patients with autosomal dominant retinitis pigmentosa (in Japanese). Nippon Ganka Gakkai Zasshi. 1992;96:237–42.PubMed
3.
Zurück zum Zitat Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K, et al. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest Ophthalmol Vis Sci. 2014;55:7369–75.CrossRefPubMed Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K, et al. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest Ophthalmol Vis Sci. 2014;55:7369–75.CrossRefPubMed
4.
Zurück zum Zitat Makarov EM, Makarova OV, Urlaub H, Gentzel M, Will CL, Wilm M, et al. Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome. Science. 2002;298:2205–8.CrossRefPubMed Makarov EM, Makarova OV, Urlaub H, Gentzel M, Will CL, Wilm M, et al. Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome. Science. 2002;298:2205–8.CrossRefPubMed
5.
Zurück zum Zitat Sato H, Wada Y, Itabashi T, Nakamura M, Kawamura M, Tamai M. Mutations in the pre-mRNA splicing gene, PRPF31, in Japanese families with autosomal dominant retinitis pigmentosa. Am J Ophthalmol. 2005;140:537–40.CrossRefPubMed Sato H, Wada Y, Itabashi T, Nakamura M, Kawamura M, Tamai M. Mutations in the pre-mRNA splicing gene, PRPF31, in Japanese families with autosomal dominant retinitis pigmentosa. Am J Ophthalmol. 2005;140:537–40.CrossRefPubMed
7.
Zurück zum Zitat Yang Y, Tian D, Lee J, Zeng J, Zhang H, Chen S, et al. Clinical and genetic identification of a large Chinese family with autosomal dominant retinitis pigmentosa. Ophthalmic Genet. 2015;36:64–9.CrossRefPubMed Yang Y, Tian D, Lee J, Zeng J, Zhang H, Chen S, et al. Clinical and genetic identification of a large Chinese family with autosomal dominant retinitis pigmentosa. Ophthalmic Genet. 2015;36:64–9.CrossRefPubMed
8.
Zurück zum Zitat Xu F, Sui R, Liang X, Li H, Jiang R, Dong F. Novel PRPF31 mutations associated with Chinese autosomal dominant retinitis pigmentosa patients. Mol Vis. 2012;18:3021–8.PubMedPubMedCentral Xu F, Sui R, Liang X, Li H, Jiang R, Dong F. Novel PRPF31 mutations associated with Chinese autosomal dominant retinitis pigmentosa patients. Mol Vis. 2012;18:3021–8.PubMedPubMedCentral
10.
Zurück zum Zitat Abu-Safieh L, Vithana EN, Mantel I, Holder GE, Pelosini L, Bird AC, et al. A large deletion in the adRP gene PRPF31: evidence that haploinsufficiency is the cause of disease. Mol Vis. 2006;12:384–8.PubMed Abu-Safieh L, Vithana EN, Mantel I, Holder GE, Pelosini L, Bird AC, et al. A large deletion in the adRP gene PRPF31: evidence that haploinsufficiency is the cause of disease. Mol Vis. 2006;12:384–8.PubMed
11.
Zurück zum Zitat Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. ISCEV standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69–77.CrossRefPubMed Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. ISCEV standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69–77.CrossRefPubMed
21.
Zurück zum Zitat Sullivan LS, Bowne SJ, Reeves MJ, Blain D, Goetz K, Ndifor V, et al. Prevalence of mutations in eyeGENE probands with a diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013;54:6255–61.CrossRefPubMedPubMedCentral Sullivan LS, Bowne SJ, Reeves MJ, Blain D, Goetz K, Ndifor V, et al. Prevalence of mutations in eyeGENE probands with a diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013;54:6255–61.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Rio Frio T, Wade NM, Ransijn A, Berson EL, Beckmann JS, Rivolta C. Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay. J Clin Invest. 2008;118:1519–31.CrossRefPubMedPubMedCentral Rio Frio T, Wade NM, Ransijn A, Berson EL, Beckmann JS, Rivolta C. Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay. J Clin Invest. 2008;118:1519–31.CrossRefPubMedPubMedCentral
23.
24.
Zurück zum Zitat Van Cauwenbergh C, Coppieters F, Roels D, De Jaegere S, Flipts H, De Zaeytijd J, et al. Mutations in splicing factor genes are a major cause of autosomal dominant retinitis pigmentosa in Belgian families. PLoS One. 2017;12:e0170038.CrossRefPubMedPubMedCentral Van Cauwenbergh C, Coppieters F, Roels D, De Jaegere S, Flipts H, De Zaeytijd J, et al. Mutations in splicing factor genes are a major cause of autosomal dominant retinitis pigmentosa in Belgian families. PLoS One. 2017;12:e0170038.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Coussa RG, Chakarova C, Ajlan R, Taha M, Kavalec C, Gomolin J, et al. Genotype and phenotype studies in autosomal dominant retinitis pigmentosa (adRP) of the French Canadian founder population. Invest Ophthalmol Vis Sci. 2015;56:8297–305.CrossRefPubMedPubMedCentral Coussa RG, Chakarova C, Ajlan R, Taha M, Kavalec C, Gomolin J, et al. Genotype and phenotype studies in autosomal dominant retinitis pigmentosa (adRP) of the French Canadian founder population. Invest Ophthalmol Vis Sci. 2015;56:8297–305.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Sullivan LS, Bowne SJ, Birch DG, Hughbanks-Wheaton D, Heckenlively JR, Lewis RA, et al. Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families. Invest Ophthalmol Vis Sci. 2006;47:3052–64.CrossRefPubMedPubMedCentral Sullivan LS, Bowne SJ, Birch DG, Hughbanks-Wheaton D, Heckenlively JR, Lewis RA, et al. Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families. Invest Ophthalmol Vis Sci. 2006;47:3052–64.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Waseem NH, Vaclavik V, Webster A, Jenkins SA, Bird AC, Bhattacharya SS. Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2007;48:1330–4.CrossRefPubMed Waseem NH, Vaclavik V, Webster A, Jenkins SA, Bird AC, Bhattacharya SS. Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2007;48:1330–4.CrossRefPubMed
28.
Zurück zum Zitat Gandra M, Anandula V, Authiappan V, Sundaramurthy S, Raman R, Bhattacharya S, et al. Retinitis pigmentosa: mutation analysis of RHO, PRPF31, RP1, and IMPDH1 genes in patients from India. Mol Vis. 2008;14:1105–13.PubMedPubMedCentral Gandra M, Anandula V, Authiappan V, Sundaramurthy S, Raman R, Bhattacharya S, et al. Retinitis pigmentosa: mutation analysis of RHO, PRPF31, RP1, and IMPDH1 genes in patients from India. Mol Vis. 2008;14:1105–13.PubMedPubMedCentral
29.
Zurück zum Zitat Vithana EN, Abu-Safieh L, Pelosini L, Winchester E, Hornan D, Bird AC, et al. Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance? Invest Ophthalmol Vis Sci. 2003;44:4204–9.CrossRefPubMed Vithana EN, Abu-Safieh L, Pelosini L, Winchester E, Hornan D, Bird AC, et al. Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance? Invest Ophthalmol Vis Sci. 2003;44:4204–9.CrossRefPubMed
30.
Zurück zum Zitat Suto K, Hosono K, Takahashi M, Hirami Y, Arai Y, Nagase Y, et al. Clinical phenotype in ten unrelated Japanese patients with mutations in the EYS gene. Ophthalmic Genet. 2014;35:25–34.CrossRefPubMed Suto K, Hosono K, Takahashi M, Hirami Y, Arai Y, Nagase Y, et al. Clinical phenotype in ten unrelated Japanese patients with mutations in the EYS gene. Ophthalmic Genet. 2014;35:25–34.CrossRefPubMed
31.
Zurück zum Zitat Hafler BP, Comander J, Weigel DiFranco C, Place EM, Pierce EA. Course of ocular function in PRPF31 retinitis pigmentosa. Semin Ophthalmol. 2016;31:49–52.CrossRefPubMed Hafler BP, Comander J, Weigel DiFranco C, Place EM, Pierce EA. Course of ocular function in PRPF31 retinitis pigmentosa. Semin Ophthalmol. 2016;31:49–52.CrossRefPubMed
32.
Zurück zum Zitat Al-Maghtheh M, Vithana E, Tarttelin E, Jay M, Evans K, Moore T, et al. Evidence for a major retinitis pigmentosa locus on 19q13.4 (RP11) and association with a unique bimodal expressivity phenotype. Am J Hum Genet. 1996;59:864–71.PubMedPubMedCentral Al-Maghtheh M, Vithana E, Tarttelin E, Jay M, Evans K, Moore T, et al. Evidence for a major retinitis pigmentosa locus on 19q13.4 (RP11) and association with a unique bimodal expressivity phenotype. Am J Hum Genet. 1996;59:864–71.PubMedPubMedCentral
34.
Zurück zum Zitat Chen X, Liu Y, Sheng X, Tam PO, Zhao K, Chen X. PRPF4 mutations cause autosomal dominant retinitis pigmentosa. Hum Mol Genet. 2014;23:2926–39.CrossRefPubMed Chen X, Liu Y, Sheng X, Tam PO, Zhao K, Chen X. PRPF4 mutations cause autosomal dominant retinitis pigmentosa. Hum Mol Genet. 2014;23:2926–39.CrossRefPubMed
35.
Zurück zum Zitat Tanackovic G, Ransijn A, Ayuso C, Harper S, Berson EL, Rivolta C. A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa. Am J Hum Genet. 2011;88:643–9.CrossRefPubMedPubMedCentral Tanackovic G, Ransijn A, Ayuso C, Harper S, Berson EL, Rivolta C. A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa. Am J Hum Genet. 2011;88:643–9.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Tarttelin EE, Plant C, Weissenbach J, Bird AC, Bhattacharya SS, Inglehearn CF. A new family linked to the RP13 locus for autosomal dominant retinitis pigmentosa on distal 17p. J Med Genet. 1996;33:518–20.CrossRefPubMedPubMedCentral Tarttelin EE, Plant C, Weissenbach J, Bird AC, Bhattacharya SS, Inglehearn CF. A new family linked to the RP13 locus for autosomal dominant retinitis pigmentosa on distal 17p. J Med Genet. 1996;33:518–20.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Tanackovic G, Ransijn A, Thibault P, Abou Elela S, Klinck R, Berson EL, et al. PRPF mutations are associated with generalised defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. Hum Mol Genet. 2011;20:2116–30.CrossRefPubMedPubMedCentral Tanackovic G, Ransijn A, Thibault P, Abou Elela S, Klinck R, Berson EL, et al. PRPF mutations are associated with generalised defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. Hum Mol Genet. 2011;20:2116–30.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Pan X, Chen X, Liu X, Gao X, Kang X, Xu Q, et al. Mutation analysis of pre-mRNA splicing genes in Chinese families with retinitis pigmentosa. Mol Vis. 2014;20:770–9.PubMedPubMedCentral Pan X, Chen X, Liu X, Gao X, Kang X, Xu Q, et al. Mutation analysis of pre-mRNA splicing genes in Chinese families with retinitis pigmentosa. Mol Vis. 2014;20:770–9.PubMedPubMedCentral
39.
Zurück zum Zitat Makarova OV, Makarov EM, Liu S, Vornlocher HP, Lührmann R. Protein 61K, encoded by a gene (PRPF31) linked to autosomal dominant retinitis pigmentosa, is required for U4/U6*U5 tri-snRNP formation and pre-mRNA splicing. EMBO J. 2002;21:1148–57.CrossRefPubMedPubMedCentral Makarova OV, Makarov EM, Liu S, Vornlocher HP, Lührmann R. Protein 61K, encoded by a gene (PRPF31) linked to autosomal dominant retinitis pigmentosa, is required for U4/U6*U5 tri-snRNP formation and pre-mRNA splicing. EMBO J. 2002;21:1148–57.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Yuan L, Kawada M, Havlioglu N, Tang H, Wu JY. Mutations in PRPF31 inhibit pre-mRNA splicing of rhodopsin gene and cause apoptosis of retinal cells. J Neurosci. 2005;25:748–57.CrossRefPubMedPubMedCentral Yuan L, Kawada M, Havlioglu N, Tang H, Wu JY. Mutations in PRPF31 inhibit pre-mRNA splicing of rhodopsin gene and cause apoptosis of retinal cells. J Neurosci. 2005;25:748–57.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Pang CP, Lam DS. Differential occurrence of mutations causative of eye diseases in the Chinese population. Hum Mutat. 2002;19:189–208.CrossRefPubMed Pang CP, Lam DS. Differential occurrence of mutations causative of eye diseases in the Chinese population. Hum Mutat. 2002;19:189–208.CrossRefPubMed
Metadaten
Titel
Long-term clinical course of 2 Japanese patients with PRPF31-related retinitis pigmentosa
verfasst von
Kentaro Kurata
Katsuhiro Hosono
Yoshihiro Hotta
Publikationsdatum
05.01.2018
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 2/2018
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-017-0560-7

Weitere Artikel der Ausgabe 2/2018

Japanese Journal of Ophthalmology 2/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.